
Sign up to save your podcasts
Or


Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween?
We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna’s struggles following its Covid-19 vaccine boom.
By STAT4.5
320320 ratings
Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween?
We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna’s struggles following its Covid-19 vaccine boom.

1,993 Listeners

756 Listeners

1,105 Listeners

818 Listeners

498 Listeners

125 Listeners

6,097 Listeners

61 Listeners

85 Listeners

34 Listeners

5,576 Listeners

55 Listeners

21 Listeners

403 Listeners

17 Listeners

11 Listeners